Buscar

01/10/2024 Efficacy of Food Industry By-Product ß-Glucan/Chitin-Chitosan on Lipid Profile of Overweight and Obese Individuals: Sustainability and Nutraceuticals
Santisteban, V, Muñoz-Garcia, N, López-Yerena, A, Puntes, M, Badimon, L, Padro, T. Efficacy of Food Industry By-Product ß-Glucan/Chitin-Chitosan on Lipid Profile of Overweight and Obese Individuals: Sustainability and Nutraceuticals. Nutrients. 2024; 16(19)DOI:10.3390/nu16193420. PMID:39408385. IF:5.000(Q1/2D).
01/10/2024 Understanding sex-based differences by adverse events
Perelló, PM, Hurtado, JC, Rodríguez, MP, Arbós, RMA. Understanding sex-based differences by adverse events. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135DOI:. PMID:. IF:3.300(Q2/4D).
01/10/2024 Effectiveness, adequacy and costs of the antibiotic treatment in adult patients with non-cystic fibrosis bronchiectasis and primary infection by Pseudomonas aeruginosa
Espinoza, CED, Carrillo, DLR, Simonetti, AF, Pereyra, FG, De Andrade, FC, Schlegel, PA, Ysasis, YM, Reus, FSA, Pestana, MJC, Arbos, RMA. Effectiveness, adequacy and costs of the antibiotic treatment in adult patients with non-cystic fibrosis bronchiectasis and primary infection by Pseudomonas aeruginosa. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135DOI:. PMID:. IF:3.300(Q2/4D).
01/10/2024 Drug-induced liver injury (DILI) due anakinra in adult-onset Still's disease (AOSD): Two case reports and review
Pestana, MJC, Hosey, KCA, Arbós, RA. Drug-induced liver injury (DILI) due anakinra in adult-onset Still's disease (AOSD): Two case reports and review. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135DOI:. PMID:. IF:3.300(Q2/4D).
24/09/2024 Escalating costs of innovative medicines: perspective and proposals
Vallano, A, Pontes, C. Escalating costs of innovative medicines: perspective and proposals. Frontiers in Public Health. 2024; 12DOI:10.3389/fpubh.2024.1449707. PMID:39381757. IF:3.400(Q1/2D).
14/06/2024 Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study
Ríos, J, Sapena, V, Marino, Z, Bruix, J, Forns, X, Morros, R, Reig, M, Torres, F, Pontes, C. Incidence of Liver and Non-liver Cancers After Hepatitis C Virus Eradication: A Population-Based Cohort Study. Drugs-Real World Outcomes. 2024; 11(3)DOI:10.1007/s40801-024-00437-y. PMID:38874848. IF:(Q/D).
01/06/2024 Cardiometabolic sex-specific response to a natural polysaccharide in individuals with obesity
Villaplana, VDS, Muñoz, N, Puntes, M, Badimón, L, Padró, T. Cardiometabolic sex-specific response to a natural polysaccharide in individuals with obesity. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
24/04/2024 First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug
Pieren, M, Gutiérrez-Solana, AA, Arbós, RMA, Boyle, GW, Davila, M, Davy, M, Gitzinger, M, Husband, L, Martínez-Martínez, MS, Mazarro, DO, Pefani, E, Penman, SL, Remuiñán, MJ, Vlasakakis, G, Zeitlinger, M, Dale, GE. First-in-human study of alpibectir (BVL-GSK098), a novel potent anti-TB drug. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2024; 79(6)DOI:10.1093/jac/dkae107. PMID:38656557. IF:3.600(Q2/3D).
25/03/2024 Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans
Padro, T, Santisteban, V, Huedo, P, Puntes, M, Aguiló, M, Espadaler-Mazo, J, Badimon, L. Lactiplantibacillus plantarum strains KABP011, KABP012, and KABP013 modulate bile acids and cholesterol metabolism in humans. CARDIOVASCULAR RESEARCH. 2024; 120(7)DOI:10.1093/cvr/cvae061. PMID:38525555. IF:13.300(Q1/1D).
11/10/2023 Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units
Moraga P., Prieto P., Conradie A., Benhayoun M., Rousell V., Davy M., Fuhr U., Antonijoan Arbos R., Abad-Santos F., Portolés A., Van Duinen J., Carcas A.J., Borobia A.M.. Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units. CTS-Clinical and Translational Science. 2023; 16(12)DOI:10.1111/cts.13655. PMID:37818923. IF:3.100(Q2/5D).
01/02/2023 The role of opioid transmission in music-induced pleasure
Mas-Herrero, E, Ferreri, L, Cardona, G, Zatorre, RJ, Pla-Junca, F, Antonijoan, RM, Riba, J, Valle, M, Rodriguez-Fornells, A. The role of opioid transmission in music-induced pleasure. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2023; 1520(1)DOI:10.1111/nyas.14946. PMID:36514207. IF:4.100(Q1/2D).
01/01/2022 A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis
Soria J.M., Mojal S., Martinez-Perez A., Acosta F.R., López S., Miqueleiz S., Rodriguez D., Quijada M.A., Cardenas A., Vidal F., Remacha A., Antonijoan R.M., Souto J.C.. A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis. HAEMATOLOGICA. 2022; 107(9)DOI:10.3324/haematol.2022.281068. PMID:35545920. IF:10.100(Q1/2D).
01/01/2022 An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol
Krolewiecki A., Enbiale W., Gandasegui J., van Lieshout L., Kepha S., Messa Junior A., Bengtson M., Gelaye W., Escola V., Martinez-Valladares M., Cambra-Pellejà M., Algorta J., Martí-Soler H., Fleitas P., Ballester M.R., Doyle S.R., Williams N.A., Legarda A., Mandomando I., Mwandawiro C., Muñoz J.. An adaptive phase II/III safety and efficacy randomized controlled trial of single day or three-day fixed-dose albendazole-ivermectin co-formulation versus albendazole for the treatment of Trichuris trichiura and other STH infections. ALIVE trial protocol. Gates Open Research. 2022; 6DOI:10.12688/gatesopenres.13615.1. PMID:. IF:(Q/D).
01/04/2023 Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults
De la Serna, E, Puig, O, Mezquida, G, Moreno-Izco, L, Merchan-Naranjo, J, Amoretti, S, Ruiz, P, Gonzalez-Pinto, A, Molina-Garcia, M, Corripio, I, Vieta, E, Baeza, I, Berge, D, Penades, R, Sanchez-Torres, A, Cuesta, MJ, Bernardo, M, Castro-Fornieles, J. Relationship between cognition and age at onset of first-episode psychosis: comparative study between adolescents, young adults, and adults. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY. 2023; 32(4)DOI:10.1007/s00787-021-01901-8. PMID:34714406. IF:6.000(Q1/1D).
10/01/2022 Target selection for deep brain stimulation in treatment resistant schizophrenia
Corripio, I, Roldan, A, McKenna, P, Sarro, S, Alonso-Solis, A, Salgado, L, Alvarez, E, Molet, J, Pomarol-Clotet, E, Portella, M. Target selection for deep brain stimulation in treatment resistant schizophrenia. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2022; 112DOI:10.1016/j.pnpbp.2021.110436. PMID:34517055. IF:5.600(Q1/2D).
01/01/2022 Ayahuasca may help to improve self-compassion and self-criticism capacities
Dominguez-Clave, E, Soler, J, Elices, M, Franquesa, A, Alvarez, E, Pascual, JC. Ayahuasca may help to improve self-compassion and self-criticism capacities. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL. 2022; 37(1)DOI:10.1002/hup.2807. PMID:34411343. IF:1.700(Q3/8D).
01/01/2022 Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years
Frangou, S, Modabbernia, A, Williams, SCR, Papachristou, E, Doucet, GE, Agartz, I, Aghajani, M, Akudjedu, TN, Albajes-Eizagirre, A, Alnaes, D, Alpert, KI, Andersson, M, Andreasen, NC, Andreassen, OA, Asherson, P, Banaschewski, T, Bargallo, N, Baumeister, S, Baur-Streubel, R, Bertolino, A, Bonvino, A, Boomsma, DI, Borgwardt, S, Bourque, J, Brandeis, D, Breier, A, Brodaty, H, Brouwer, RM, Buitelaar, JK, Busatto, GF, Buckner, RL, Calhoun, V, Canales-Rodriguez, EJ, Cannon, DM, Caseras, X, Castellanos, FX, Cervenka, S, Chaim-Avancini, TM, Ching, CRK, Chubar, V, Clark, VP, Conrod, P, Conzelmann, A, Crespo-Facorro, B, Crivello, F, Crone, EA, Dale, AM, Davey, C, de Geus, EJC, de Haan, L, de Zubicaray, GI, den Braber, A, Dickie, EW, Di Giorgio, A, Doan, NT, Dorum, ES, Ehrlich, S, Erk, S, Espeseth, T, Fatouros-Bergman, H, Fisher, SE, Fouche, JP, Franke, B, Frodl, T, Fuentes-Claramonte, P, Glahn, DC, Gotlib, IH, Grabe, HJ, Grimm, O, Groenewold, NA, Grotegerd, D, Gruber, O, Gruner, P, Gur, RE, Gur, RC, Harrison, BJ, Hartman, CA, Hatton, SN, Heinz, A, Heslenfeld, DJ, Hibar, DP, Hickie, IB, Ho, BC, Hoekstra, PJ, Hohmann, S, Holmes, AJ, Hoogman, M, Hosten, N, Howells, FM, Pol, HEH, Huyser, C, Jahanshad, N, James, A, Jernigan, TL, Jiang, J, Jonsson, EG, Joska, JA, Kahn, R, Kalnin, A, Kanai, R, Klein, M, Klyushnik, TP, Koenders, L, Koops, S, Kramer, B, Kuntsi, J, Lagopoulos, J, Lazaro, L, Lebedeva, I, Lee, WH, Lesch, KP, Lochner, C, Machielsen, MWJ, Maingault, S, Martin, NG, Martinez-Zalacain, I, Mataix-Cols, D, Mazoyer, B, McDonald, C, McDonald, BC, McIntosh, AM, McMahon, KL, McPhilemy, G, Menchon, JM, Medland, SE, Meyer-Lindenberg, A, Naaijen, J, Najt, P, Nakao, T, Nordvik, JE, Nyberg, L, Oosterlaan, J, de la Foz, VOG, Paloyelis, Y, Pauli, P, Pergola, G, Pomarol-Clotet, E, Portella, MJ, Potkin, SG, Radua, J, Reif, A, Rinker, DA, Roffman, JL, Rosa, PGP, Sacchet, MD, Sachdev, PS, Salvador, R, Sanchez-Juan, P, Sarro, S, Satterthwaite, TD, Saykin, AJ, Serpa, MH, Schmaal, L, Schnell, K, Schumann, G, Sim, K, Smoller, JW, Sommer, I, Soriano-Mas, C, Stein, DJ, Strike, LT, Swagerman, SC, Tamnes, CK, Temmingh, HS, Thomopoulos, SI, Tomyshev, AS, Tordesillas-Gutierrez, D, Trollor, JN, Turner, JA, Uhlmann, A, van den Heuvel, OA, van den Meer, D, van der Wee, NJA, van Haren, NEM, van't Ent, D, van Erp, TGM, Veer, IM, Veltman, DJ, Voineskos, A, Volzke, H, Walter, H, Walton, E, Wang, L, Wang, Y, Wassink, TH, Weber, B, Wen, W, West, JD, Westlye, LT, Whalley, H, Wierenga, LM, Wittfeld, K, Wolf, DH, Worker, A, Wright, MJ, Yang, K, Yoncheva, Y, Zanetti, MV, Ziegler, GC, Thompson, PM, Dima, D, Karolinska Schizophrenia Project K. Cortical thickness across the lifespan: Data from 17,075 healthy individuals aged 3-90 years. HUMAN BRAIN MAPPING. 2022; 43(1)DOI:10.1002/hbm.25364. PMID:33595143. IF:4.800(Q1/2D).
01/01/2022 Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years
Dima, D, Modabbernia, A, Papachristou, E, Doucet, GE, Agartz, I, Aghajani, M, Akudjedu, TN, Albajes-Eizagirre, A, Alnaes, D, Alpert, KI, Andersson, M, Andreasen, NC, Andreassen, OA, Asherson, P, Banaschewski, T, Bargallo, N, Baumeister, S, Baur-Streubel, R, Bertolino, A, Bonvino, A, Boomsma, DI, Borgwardt, S, Bourque, J, Brandeis, D, Breier, A, Brodaty, H, Brouwer, RM, Buitelaar, JK, Busatto, GF, Buckner, RL, Calhoun, V, Canales-Rodriguez, EJ, Cannon, DM, Caseras, X, Castellanos, FX, Cervenka, S, Chaim-Avancini, TM, Ching, CRK, Chubar, V, Clark, VP, Conrod, P, Conzelmann, A, Crespo-Facorro, B, Crivello, F, Crone, EA, Dale, AM, Davey, C, de Geus, EJC, de Haan, L, de Zubicaray, GI, den Braber, A, Dickie, EW, Di Giorgio, A, Doan, NT, Dorum, ES, Ehrlich, S, Erk, S, Espeseth, T, Fatouros-Bergman, H, Fisher, SE, Fouche, JP, Franke, B, Frodl, T, Fuentes-Claramonte, P, Glahn, DC, Gotlib, IH, Grabe, HJ, Grimm, O, Groenewold, NA, Grotegerd, D, Gruber, O, Gruner, P, Gur, RE, Gur, RC, Harrison, B, Hartman, CA, Hatton, SN, Heinz, A, Heslenfeld, DJ, Hibar, DP, Hickie, IB, Ho, BC, Hoekstra, PJ, Hohmann, S, Holmes, AJ, Hoogman, M, Hosten, N, Howells, FM, Pol, HEH, Huyser, C, Jahanshad, N, James, A, Jernigan, TL, Jiang, JY, Jonsson, EG, Joska, JA, Kahn, R, Kalnin, A, Kanai, R, Klein, M, Klyushnik, TP, Koenders, L, Koops, S, Kramer, B, Kuntsi, J, Lagopoulos, J, Lazaro, L, Lebedeva, I, Lee, WH, Lesch, KP, Lochner, C, Machielsen, MWJ, Maingault, S, Martin, NG, Martinez-Zalacain, I, Mataix-Cols, D, Mazoyer, B, McDonald, C, McDonald, BC, McIntosh, AM, McMahon, KL, McPhilemy, G, Menchon, JM, Medland, SE, Meyer-Lindenberg, A, Naaijen, J, Najt, P, Nakao, T, Nordvik, JE, Nyberg, L, Oosterlaan, J, De la Foz, VOG, Paloyelis, Y, Pauli, P, Pergola, G, Pomarol-Clotet, E, Portella, MJ, Potkin, SG, Radua, J, Reif, A, Rinker, DA, Roffman, JL, Rosa, PGP, Sacchet, MD, Sachdev, PS, Salvador, R, Sanchez-Juan, P, Sarro, S, Satterthwaite, TD, Saykin, AJ, Serpa, MH, Schmaal, L, Schnell, K, Schumann, G, Sim, K, Smoller, JW, Sommer, I, Soriano-Mas, C, Stein, DJ, Strike, LT, Swagerman, SC, Tamnes, CK, Temmingh, HS, Thomopoulos, SI, Tomyshev, AS, Tordesillas-Gutierrez, D, Trollor, JN, Turner, JA, Uhlmann, A, van den Heuvel, OA, van den Meer, D, van der Wee, NJA, van Haren, NEM, Van't Ent, D, van Erp, TGM, Veer, IM, Veltman, DJ, Voineskos, A, Volzke, H, Walter, H, Walton, E, Wang, L, Wang, Y, Wassink, TH, Weber, B, Wen, W, West, JD, Westlye, LT, Whalley, H, Wierenga, LM, Williams, SCR, Wittfeld, K, Wolf, DH, Worker, A, Wright, MJ, Yang, K, Yoncheva, Y, Zanetti, MV, Ziegler, GC, Thompson, PM, Frangou, S, Karolinska Schizophrenia Project K. Subcortical volumes across the lifespan: Data from 18,605 healthy individuals aged 3-90 years. HUMAN BRAIN MAPPING. 2022; 43(1)DOI:10.1002/hbm.25320. PMID:33570244. IF:4.800(Q1/2D).
01/01/2022 Neonatal arterial stroke location is associated with outcome at 2 years: a voxel-based lesion-symptom mapping study
Nunez, C, Stephan-Otto, C, Arca, G, Agut, T, Arnaez, J, Cordeiro, M, Benavente-Fernandez, I, Boronat, N, Lubian-Lopez, SP, Valverde, E, Hortiguela, M, Garcia-Alix, A. Neonatal arterial stroke location is associated with outcome at 2 years: a voxel-based lesion-symptom mapping study. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2022; 107(1)DOI:10.1136/archdischild-2020-320400. PMID:33990386. IF:4.400(Q1/1D).
09/12/2021 Persons with first episode psychosis have distinct profiles of social cognition and metacognition
Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Birules, I, Barajas, A, Lorente-Rovira, E, Diaz-Cutraro, L, Verdaguer, M, Garcia-Mieres, H, Sevilla-Llewellyn-Jones, J, Gutierrez-Zotes, A, Grasa, E, Pousa, E, Huerta-Ramos, E, Pelaez, T, Barrigon, ML, Gonzalez-Higueras, F, Ruiz-Delgado, I, Cid, J, Moritz, S, Ochoa, S. Persons with first episode psychosis have distinct profiles of social cognition and metacognition. SCHIZOPHRENIA. 2021; 7(1)DOI:10.1038/s41537-021-00187-8. PMID:34887442. IF:4.966(Q2/4D).
01/12/2021 Dealing with heterogeneity of cognitive dysfunction in acute depression: a clustering approach
Vicent-Gil, M, Portella, MJ, Serra-Blasco, M, Navarra-Ventura, G, Crivilles, S, Aguilar, E, Palao, D, Cardoner, N. Dealing with heterogeneity of cognitive dysfunction in acute depression: a clustering approach. PSYCHOLOGICAL MEDICINE. 2021; 51(16)DOI:10.1017/S0033291720001567. PMID:32476636. IF:10.592(Q1/1D).
01/11/2021 Cognitive clusters in first-episode psychosis
Amoretti, S, Rabelo-da-Ponte, FD, Rosa, AR, Mezquida, G, Sanchez-Torres, AM, Fraguas, D, Cabrera, B, Lobo, A, Gonzalez-Pinto, A, Pina-Camacho, L, Corripio, I, Vieta, E, Torrent, C, de la Serna, E, Berge, D, Bioque, M, Garriga, M, Serra, M, Cuesta, MJ, Bernardo, M. Cognitive clusters in first-episode psychosis. SCHIZOPHRENIA RESEARCH. 2021; 237DOI:10.1016/j.schres.2021.08.021. PMID:34481203. IF:4.662(Q2/5D).
30/10/2021 Polymorphisms in the IL1-b gene are associated with increased Glu and Glx levels in treatment-resistant depression
Draganov, M, Arranz, MJ, Vives-Gilabert, Y, Jubero, M, de Diego-Adelino, J, Avila-Parcet, A, Puigdemont, D, Portella, MJ. Polymorphisms in the IL1-b gene are associated with increased Glu and Glx levels in treatment-resistant depression. PSYCHIATRY RESEARCH-NEUROIMAGING. 2021; 316DOI:10.1016/j.pscychresns.2021.111348. PMID:34371477. IF:2.493(Q3/8D).
19/10/2021 A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood
Gasso, P, Rodriguez, N, Martinez-Pinteno, A, Mezquida, G, Ribeiro, M, Gonzalez-Penas, J, Zorrilla, I, Martinez-Sadurni, L, Rodriguez-Jimenez, R, Corripio, I, Sarro, S, Ibanez, A, Usall, J, Lobo, A, Moren, C, Cuesta, MJ, Parellada, M, Gonzalez-Pinto, A, Berrocoso, E, Bernardo, M, Mas, S. A longitudinal study of gene expression in first-episode schizophrenia; exploring relapse mechanisms by co-expression analysis in peripheral blood. Translational Psychiatry. 2021; 11(1)DOI:10.1038/s41398-021-01645-8. PMID:34667144. IF:7.989(Q1/2D).
01/10/2021 Unhappy While Depressed: Examining the Dimensionality, Reliability and Validity of the Subjective Happiness Scale in a Spanish Sample of Patients with Depressive Disorders
Feliu-Soler, A, de Diego-Adelino, J, Luciano, JV, Iraurgi, I, Alemany, C, Puigdemont, D, Perez, V, Portella, MJ, Trujols, J. Unhappy While Depressed: Examining the Dimensionality, Reliability and Validity of the Subjective Happiness Scale in a Spanish Sample of Patients with Depressive Disorders. International Journal of Environmental Research and Public Health. 2021; 18(20)DOI:10.3390/ijerph182010964. PMID:34682709. IF:4.614(Q1/3D).
01/10/2021 Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis
Gonzalez-Blanco, L, Garcia-Portilla, MP, Gutierrez, M, Mezquida, G, Cuesta, MJ, Urbiola, E, Amoretti, S, Barcones, F, Gonzalez-Pinto, A, Pina-Camacho, L, Corripio, I, Vieta, E, Baeza, I, Toll, A, Saiz, PA, Bobes, J, Bernardo, M. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis. SCHIZOPHRENIA RESEARCH. 2021; 236DOI:10.1016/j.schres.2021.07.017. PMID:34365082. IF:4.662(Q2/5D).
01/10/2021 Predictors of response to pharmacological treatments in treatment-resistant schizophrenia - A systematic review and meta-analysis
Seppala, A, Pylvanainen, J, Lehtiniemi, H, Hirvonen, N, Corripio, I, Koponen, H, Seppala, J, Ahmed, A, Isohanni, M, Miettunen, J, Jaaskelainen, E. Predictors of response to pharmacological treatments in treatment-resistant schizophrenia - A systematic review and meta-analysis. SCHIZOPHRENIA RESEARCH. 2021; 236DOI:10.1016/j.schres.2021.08.005. PMID:34496316. IF:4.662(Q2/5D).
01/09/2021 Moderators of cognitive insight outcome in metacognitive training for first-episode psychosis
Gonzalez-Blanch, C, Birules, I, Pousa, E, Barrigon, ML, Lopez-Carrilero, R, Lorente-Rovira, E, Ayesa-Arriola, R, Setien-Suero, E, Barajas, A, Grasa, EM, Ruiz-Delgado, I, Gonzalez-Higueras, F, Cid, J, Ochoa, S. Moderators of cognitive insight outcome in metacognitive training for first-episode psychosis. JOURNAL OF PSYCHIATRIC RESEARCH. 2021; 141DOI:10.1016/j.jpsychires.2021.06.040. PMID:34186271. IF:5.250(Q2/4D).
01/09/2021 The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory
Ballesteros, A, Torres, AMS, Lopez-Ilundain, J, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Pina-Camacho, L, Corripio, I, Vieta, E, de la Serna, E, Mane, A, Bioque, M, Moreno-Izco, L, Espliego, A, Lorente-Omenaca, R, Amoretti, S, Bernardo, M, Cuesta, MJ. The longitudinal effect of antipsychotic burden on psychosocial functioning in first-episode psychosis patients: the role of verbal memory. PSYCHOLOGICAL MEDICINE. 2021; 51(12)DOI:10.1017/S003329172000080X. PMID:32326991. IF:10.592(Q1/1D).
01/09/2021 Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain
Pascual, JC, Martin-Blanco, A, Soler, J. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain. CNS DRUGS. 2021; 35(9)DOI:10.1007/s40263-021-00852-7. PMID:34370282. IF:6.497(Q1/2D).
01/08/2021 The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years
Verdolini, N, Amoretti, S, Mezquida, G, Cuesta, MJ, Pina-Camacho, L, Garcia-Rizo, C, Lobo, A, Gonzalez-Pinto, A, Merchan-Naranjo, J, Corripio, I, Salagre, E, Baeza, I, Berge, D, Garriga, M, Bioque, M, Vallespir, C, Serra, M, Vieta, E, Bernardo, M. The effect of family environment and psychiatric family history on psychosocial functioning in first-episode psychosis at baseline and after 2 years. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021; 49DOI:10.1016/j.euroneuro.2021.03.015. PMID:33857739. IF:5.415(Q1/3D).
01/01/2023 Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls
Butjosa, A, Usall, J, Vila-Badia, R, Mezquida, G, Cuesta, MJ, Rodriguez-Toscano, E, Amoretti, S, Lobo, A, Gonzalez-Pinto, A, Espliego, A, Corripio, I, Vieta, E, Baeza, I, Berge, D, Bernardo, M. Impact of traumatic life events on clinical variables of individuals with first-episode psychosis and healthy controls. INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY. 2023; 69(1)DOI:10.1177/00207640211070398. PMID:35068217. IF:2.500(Q2/5D).
12/08/2022 An adapted scale to evaluate insight in Prader-Willi Syndrome
Cobo J., Coronas R., Pousa E., Oliva J.-C., Giménez-Palop O., Caixàs A.. An adapted scale to evaluate insight in Prader-Willi Syndrome. MEDICINA CLINICA. 2022; 159(3)DOI:10.1016/j.medcli.2021.07.015. PMID:34696903. IF:3.900(Q2/4D).
01/07/2022 Cognitive and quality-of-life related factors of body mass index (BMI) improvement after deep brain stimulation in the subcallosal cingulate and nucleus accumbens in treatment-refractory chronic anorexia nervosa
Perez, V, Villalba-Martinez, G, Elices, M, Manero, RM, Salgado, P, Gines, JM, Guardiola, R, Cedron, C, Polo, M, Delgado-Martinez, I, Conesa, G, Medrano, S, Portella, MJ. Cognitive and quality-of-life related factors of body mass index (BMI) improvement after deep brain stimulation in the subcallosal cingulate and nucleus accumbens in treatment-refractory chronic anorexia nervosa. EUROPEAN EATING DISORDERS REVIEW. 2022; 30(4)DOI:10.1002/erv.2895. PMID:35322504. IF:5.300(Q1/2D).
01/07/2022 Is intensive home-treatment a real alternative to classical hospitalization for managing acute psychiatric processes? Insights from clinical practice
Martín-Blanco A., Calvo-Saiz L., Baccarin J., González-Fernández A., Keymer-Gausset A., Vieira-Costa S., Ribas-Fitó N., Garcia-Ribera C.. Is intensive home-treatment a real alternative to classical hospitalization for managing acute psychiatric processes? Insights from clinical practice. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2022; 15(3)DOI:10.1016/j.rpsm.2021.11.001. PMID:36272741. IF:9.200(Q1/1D).
04/05/2022 Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review
De Diego-Adelino, J, Crespo, JM, Mora, F, Neyra, A, Iborra, P, Gutierrez-Rojas, L, Salonia, SF. Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review. Expert Opinion On Drug Safety. 2022; 21(5)DOI:10.1080/14740338.2022.2019705. PMID:34964415. IF:3.100(Q3/6D).
20/04/2022 The relationship between jumping to conclusions and social cognition in first-episode psychosis
Diaz-Cutraro, L, Lopez-Carrilero, R, Garcia-Mieres, H, Ferrer-Quintero, M, Verdaguer-Rodriguez, M, Barajas, A, Grasa, E, Pousa, E, Lorente, E, Barrigon, ML, Ruiz-Delgado, I, Gonzalez-Higueras, F, Cid, J, Mas-Exposito, L, Corripio, I, Birules, I, Pelaez, T, Luengo, A, Beltran, M, Torres-Hernandez, P, Palma-Sevillano, C, Moritz, S, Garety, P, Ochoa, S. The relationship between jumping to conclusions and social cognition in first-episode psychosis. SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-022-00221-3. PMID:35853903. IF:5.400(Q2/3D).
01/04/2022 "Skills for pills": The dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder
Soler, J, Casellas-Pujol, E, Fernandez-Felipe, I, Martin-Blanco, A, Almenta, D, Pascual, JC. "Skills for pills": The dialectical-behavioural therapy skills training reduces polypharmacy in borderline personality disorder. ACTA PSYCHIATRICA SCANDINAVICA. 2022; 145(4)DOI:10.1111/acps.13403. PMID:35088405. IF:6.700(Q1/2D).
01/04/2022 Borderline personality traits mediate the relationship between low perceived social support and non-suicidal self-injury in a clinical sample of adolescents
Mendez, I, Sintes, A, Pascual, JC, Punti, J, Lara, A, Briones-Buixassa, L, Nicolaou, S, Schmidt, C, Romero, S, Fernandez, M, Farres, CCI, Soler, J, Santamarina-Perez, P, Vega, D. Borderline personality traits mediate the relationship between low perceived social support and non-suicidal self-injury in a clinical sample of adolescents. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302DOI:10.1016/j.jad.2022.01.065. PMID:35038480. IF:6.600(Q1/2D).
01/04/2022 Is the effect of cognitive reserve in longitudinal outcomes in first-episode psychoses dependent on the use of cannabis?
Amoretti, S, Verdolini, N, Varo, C, Mezquida, G, Sanchez-Torres, AM, Vieta, E, Garcia-Rizo, C, Lobo, A, Gonzalez-Pinto, A, Abregu-Crespo, R, Corripio, I, Serra, M, de la Serna, E, Mane, A, Ramos-Quiroga, JA, Ribases, M, Cuesta, MJ, Bernardo, M. Is the effect of cognitive reserve in longitudinal outcomes in first-episode psychoses dependent on the use of cannabis?. JOURNAL OF AFFECTIVE DISORDERS. 2022; 302DOI:10.1016/j.jad.2022.01.077. PMID:35066012. IF:6.600(Q1/2D).
01/03/2022 Relationship between immunometabolic status and cognitive performance among major depression disorder patients
Sanchez-Carro, Y, de la Torre-Luque, A, Portella, MJ, Leal-Leturia, I, Salvat-Pujol, N, Massaneda, C, de Arriba-Arnau, A, Urretavizcaya, M, Pereto, M, Toll, A, Martinez-Ruiz, A, Ferreiros-Martinez, R, Alvarez, P, Soria, V, Lopez-Garcia, P. Relationship between immunometabolic status and cognitive performance among major depression disorder patients. PSYCHONEUROENDOCRINOLOGY. 2022; 137DOI:10.1016/j.psyneuen.2021.105631. PMID:34929555. IF:3.700(Q2/5D).
24/02/2022 Persons with first episode psychosis have distinct profiles of social cognition and metacognition (vol 9, 61, 2021)
Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Birules, I, Barajas, A, Lorente-Rovira, E, Diaz-Cutraro, L, Verdaguer, M, Garcia-Mieres, H, Sevilla-Llewellyn-Jones, J, Gutierrez-Zotes, A, Grasa, E, Pousa, E, Huerta-Ramos, E, Pelaez, T, Barrigon, ML, Gonzalez-Higueras, F, Ruiz-Delgado, I, Cid, J, Moritz, S, Ochoa, S. Persons with first episode psychosis have distinct profiles of social cognition and metacognition (vol 9, 61, 2021). SCHIZOPHRENIA. 2022; 8(1)DOI:10.1038/s41537-021-00199-4. PMID:35210466. IF:5.400(Q2/3D).
01/02/2022 The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses
Amoretti, S, Rosa, AR, Mezquida, G, Cabrera, B, Ribeiro, M, Molina, M, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Fraguas, D, Corripio, I, Vieta, E, de la Serna, E, Morro, L, Garriga, M, Torrent, C, Cuesta, MJ, Bernardo, M, PEPs Grp. The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses. PSYCHOLOGICAL MEDICINE. 2022; 52(3)DOI:10.1017/S0033291720002226. PMID:32900395. IF:6.900(Q1/1D).
01/01/2022 Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study
Baenas, I, Etxandi, M, Munguia, L, Granero, R, Mestre-Bach, G, Sanchez, I, Ortega, E, Andreu, A, Moize, VL, Fernandez-Real, JM, Tinahones, FJ, Dieguez, C, Fruhbeck, G, Le Grange, D, Tchanturia, K, Karwautz, A, Zeiler, M, Imgart, H, Zanko, A, Favaro, A, Claes, L, Shekriladze, I, Serrano-Troncoso, E, Cecilia-Costa, R, Rangil, T, Loran-Meler, ME, Soriano-Pacheco, J, Carceller-Sindreu, M, Navarrete, R, Lozano, M, Linares, R, Gudiol, C, Carratala, J, Plana, MT, Graell, M, Gonzalez-Parra, D, Gomez-del Barrio, JA, Sepulveda, AR, Sanchez-Gonzalez, J, Machado, PPP, Hakansson, A, Tury, F, Paszthy, B, Stein, D, Papezova, H, Gricova, J, Bax, B, Borisenkov, MF, Popov, SV, Gubin, DG, Petrov, IM, Isakova, D, Mustafina, SV, Kim, YR, Nakazato, M, Godart, N, van Voren, R, Ilnytska, T, Chen, J, Rowlands, K, Voderholzer, U, Monteleone, AM, Treasure, J, Jimenez-Murcia, S, Fernandez-Aranda, F. Impact of COVID-19 Lockdown in Eating Disorders: A Multicentre Collaborative International Study. Nutrients. 2022; 14(1)DOI:10.3390/nu14010100. PMID:35010974. IF:5.900(Q1/2D).
21/12/2021 Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder
Caso, JR, MacDowell, KS, Gonzalez-Pinto, A, Garcia, S, de Diego-Adelino, J, Carceller-Sindreu, M, Sarramea, F, Caballero-Villarraso, J, Gracia-Garcia, P, De la Camara, C, Aguera, L, Gomez-Lus, ML, Alba, C, Rodriguez, JM, Leza, JC. Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder. Translational Psychiatry. 2021; 11(1)DOI:10.1038/s41398-021-01755-3. PMID:34934041. IF:7.989(Q1/2D).
08/12/2021 Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment
Roberto, N, Portella, MJ, Marquie, M, Alegret, M, Hernandez, I, Mauleon, A, Rosende-Roca, M, Abdelnour, C, de Antonio, EE, Tartari, JP, Vargas, L, Lopez-Cuevas, R, Bojaryn, U, Espinosa, A, Ortega, G, Perez-Cordon, A, Sanabria, A, Orellana, A, de Rojas, I, Moreno-Grau, S, Montrreal, L, Alarcon-Martin, E, Ruiz, A, Tarraga, L, Boada, M, Valero, S. Neuropsychiatric Profile as a Predictor of Cognitive Decline in Mild Cognitive Impairment. Frontiers in Aging Neuroscience. 2021; 13DOI:10.3389/fnagi.2021.718949. PMID:34955804. IF:5.702(Q1/3D).
01/11/2021 Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis
Baeza, I, de la Serna, E, Amoretti, S, Cuesta, MJ, Diaz-Caneja, CM, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Corripio, I, Vieta, E, Puig, O, Legido, T, Bioque, M, Garcia-Rizo, C, Bernardo, M, Castro-Fornieles, J. Premorbid Characteristics as Predictors of Early Onset Versus Adult Onset in Patients With a First Episode of Psychosis. JOURNAL OF CLINICAL PSYCHIATRY. 2021; 82(6)DOI:10.4088/JCP.21m13907. PMID:34529899. IF:5.906(Q2/3D).
01/08/2023 In pursuit of full recovery in major depressive disorder
Vicent-Gil, M, Serra-Blasco, M, Navarra-Ventura, G, Trujols, J, Balanza-Martinez, V, Portella, MJ, Cardoner, N. In pursuit of full recovery in major depressive disorder. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2023; 273(5)DOI:10.1007/s00406-022-01487-5. PMID:36085532. IF:3.500(Q1/3D).
01/01/2023 Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode
Segura, AG, Mezquida, G, Martinez-Pinteno, A, Gasso, P, Rodriguez, N, Moreno-Izco, L, Amoretti, S, Bioque, M, Lobo, A, Gonzalez-Pinto, A, Garcia-Alcon, A, Roldan-Bejarano, A, Vieta, E, de la Serna, E, Toll, A, Cuesta, MJ, Mas, S, Bernardo, M. Link between cognitive polygenic risk scores and clinical progression after a first-psychotic episode. PSYCHOLOGICAL MEDICINE. 2023; 53(10)DOI:10.1017/S0033291722001544. PMID:35678455. IF:5.900(Q1/1D).
18/11/2022 Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up Study
Bioque, M, Matias-Martins, AC, Llorca-Bofi, V, Mezquida, G, Cuesta, MJ, Vieta, E, Amoretti, S, Lobo, A, Gonzalez-Pinto, A, Moreno, C, Roldan, A, Martinez-Aran, A, Baeza, I, Berge, D, Garcia-Rizo, C, Herrero, SM, Bernardo, M. Neutrophil to Lymphocyte Ratio in Patients With a First Episode of Psychosis: A Two-Year Longitudinal Follow-up Study. SCHIZOPHRENIA BULLETIN. 2022; 48(6)DOI:10.1093/schbul/sbac089. PMID:35876785. IF:6.600(Q1/3D).
01/11/2022 Online psychological interventions to improve symptoms in multiple sclerosis: A systematic review
Montanes-Masias, B, Bort-Roig, J, Pascual, JC, Soler, J, Briones-Buixassa, L. Online psychological interventions to improve symptoms in multiple sclerosis: A systematic review. ACTA NEUROLOGICA SCANDINAVICA. 2022; 146(5)DOI:10.1111/ane.13709. PMID:36121184. IF:3.500(Q2/5D).
01/11/2022 Heterogeneity in Response to MCT and Psychoeducation: A Feasibility Study Using Latent Class Mixed Models in First-Episode Psychosis
Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Diaz-Cutraro, L, Verdaguer-Rodriguez, M, Garcia-Mieres, H, Huerta-Ramos, E, Gomez-Benito, J, Pelaez, T, Birules, I, Barajas, A, Pousa, E, Barrigon, M, Gutierrez-Zotes, A, Grasa, E, Ruiz-Delgado, I, Lorente-Rovira, E, Cid, J, Ochoa, S. Heterogeneity in Response to MCT and Psychoeducation: A Feasibility Study Using Latent Class Mixed Models in First-Episode Psychosis. Healthcare. 2022; 10(11)DOI:10.3390/healthcare10112155. PMID:36360496. IF:2.800(Q3/6D).
20/10/2022 Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: Differences between males and females
Serra-Navarro, M, Amoretti, S, Verdolini, N, Forte, MF, Sanchez-Torres, AM, Vieta, E, Clougher, D, Lobo, A, Gonzalez-Pinto, A, Panadero, R, Roldan, A, Carvalho, AF, de la Serna, E, Toll, A, Ramos-Quiroga, JA, Torrent, C, Cuesta, MJ, Bernardo, M. Influence of clinical and neurocognitive factors in psychosocial functioning after a first episode non-affective psychosis: Differences between males and females. Frontiers in Psychiatry. 2022; 13DOI:10.3389/fpsyt.2022.982583. PMID:36339856. IF:4.700(Q2/4D).
01/10/2022 Males and females with first episode psychosis present distinct profiles of social cognition and metacognition
Ferrer-Quintero, M, Fernandez, D, Lopez-Carrilero, R, Birules, I, Barajas, A, Lorente-Rovira, E, Luengo, A, Diaz-Cutraro, L, Verdaguer, M, Garcia-Mieres, H, Gutierrez-Zotes, A, Grasa, E, Pousa, E, Huerta-Ramos, E, Pelaez, T, Barrigon, ML, Gomez-Benito, J, Gonzalez-Higueras, F, Ruiz-Delgado, I, Cid, J, Moritz, S, Sevilla-Llewellyn-Jones, J, Ochoa, S. Males and females with first episode psychosis present distinct profiles of social cognition and metacognition. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2022; 272(7)DOI:10.1007/s00406-022-01438-0. PMID:35802165. IF:4.700(Q1/3D).
01/10/2022 Shape analysis of subcortical structures in obsessive-compulsive disorder and the relationship with comorbid anxiety, depression, and medication use: A meta-analysis by the OCD Brain Imaging Consortium
Fouche, JP, Groenewold, NA, Sevenoaks, T, Heany, S, Lochner, C, Alonso, P, Batistuzzo, MC, Cardoner, N, Ching, CRK, de Wit, SJ, Gutman, B, Hoexter, MQ, Jahanshad, N, Kim, M, Kwon, JS, Mataix-Cols, D, Menchon, JM, Miguel, EC, Nakamae, T, Phillips, ML, Pujol, J, Sakai, Y, Yun, JY, Soriano-Mas, C, Thompson, PM, Yamada, K, Veltman, DJ, van den Heuvel, OA, Stein, DJ. Shape analysis of subcortical structures in obsessive-compulsive disorder and the relationship with comorbid anxiety, depression, and medication use: A meta-analysis by the OCD Brain Imaging Consortium. Brain and Behavior. 2022; 12(10)DOI:10.1002/brb3.2755. PMID:36106505. IF:3.100(Q2/3D).
01/10/2022 Clinical insight in first-episode psychosis: Clinical, neurocognitive and metacognitive predictors
Pousa, E, Brebion, G, Lopez-Carrilero, R, Ruiz, AI, Grasa, E, Barajas, A, Pelaez, T, Alfonso-Gutierrrez-Zotes, Lorente, E, Barrigon, ML, Ruiz-Delgado, I, Gonzalez-Higueras, F, Cid, J, Perez-Sola, V, Ochoa, S. Clinical insight in first-episode psychosis: Clinical, neurocognitive and metacognitive predictors. SCHIZOPHRENIA RESEARCH. 2022; 248DOI:10.1016/j.schres.2022.08.007. PMID:36063607. IF:4.500(Q2/4D).
01/09/2022 Aging in bipolar disorder: Cognitive performance and clinical factors based on an adulthood-lifespan perspective
Montejo, L, Sole, B, Jimenez, E, Borras, R, Clougher, D, Reinares, M, Portella, MJ, Martinez-Aran, A, Vieta, E, Bonnin, CD, Torrent, C. Aging in bipolar disorder: Cognitive performance and clinical factors based on an adulthood-lifespan perspective. JOURNAL OF AFFECTIVE DISORDERS. 2022; 312DOI:10.1016/j.jad.2022.06.030. PMID:35752219. IF:6.600(Q1/2D).
01/08/2022 Randomized clinical trial of integral cognitive remediation program for major depression (INCREM)
Vicent-Gil M., González-Simarro S., Raventós B., Vera J., Marín Martínez E.D., Sabaté-Cao C., Pérez-Blanco J., Puigdemont D., de Diego-Adeliño J., Alemany C., Serra-Blasco M., Cardoner N., Portella M.J.. Randomized clinical trial of integral cognitive remediation program for major depression (INCREM). JOURNAL OF AFFECTIVE DISORDERS. 2022; 310DOI:10.1016/j.jad.2022.05.016. PMID:35545155. IF:6.600(Q1/2D).
18/07/2022 Patient-reported outcome measures (PROMs) to guide clinical care: recommendations and challenges
Trujols, J, Duran-Sindreu, S, Portella, MJ. Patient-reported outcome measures (PROMs) to guide clinical care: recommendations and challenges. MEDICAL JOURNAL OF AUSTRALIA. 2022; 217(2)DOI:10.5694/mja2.51614. PMID:35753958. IF:11.400(Q1/2D).
01/06/2022 The network structure of cognitive deficits in first episode psychosis patients
Sánchez-Torres A.M., Peralta V., Gil-Berrozpe G.J., Mezquida G., Ribeiro M., Molina-García M., Amoretti S., Lobo A., González-Pinto A., Merchán-Naranjo J., Corripio I., Vieta E., de la Serna E., Bergé D., Bernardo M., Cuesta M.J., Cabrera B., Pons M., Abregú-Crespo R., Rapado-Castro M., Alonso-Solís A., Grasa E., González-Ortega I., Alberich S., de la Cámara C., Saz P., Aguilar E.J., Escartí M.J., Martínez L., Toll A., Gavin P., Varo C., Baeza I., Puig O., Contreras F., Saiz-Masvidal C., Álvarez L.G., Bascarán M.T.B., Fraile M.G., Rabadán A.Z., Sanchez-Pastor L., Rodriguez-Jimenez R., Usall J., Butjosa A., Sarró S., Landín-Romero R., Ibáñez Á., Moreno-Izco L., Balanzá-Martínez V.. The network structure of cognitive deficits in first episode psychosis patients. SCHIZOPHRENIA RESEARCH. 2022; 244DOI:10.1016/j.schres.2022.05.005. PMID:35594732. IF:4.500(Q2/4D).